Literature DB >> 28038352

Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice.

Franziska Richter1, Lauryn Gabby2, Kimberly A McDowell2, Caitlyn K Mulligan2, Krystal De La Rosa2, Pedrom C Sioshansi2, Farzad Mortazavi2, Ingrid Cely3, Larry C Ackerson3, Linda Tsan3, Niall P Murphy3, Nigel T Maidment3, Marie-Françoise Chesselet2.   

Abstract

How genetic variations in the dopamine transporter (DAT) combined with exposure to environmental toxins modulate the risk of Parkinson's disease remains unclear. Using unbiased stereology in DAT knock-down mice (DAT-KD) and wild-type (WT) littermates, we found that decreased DAT caused a loss of tyrosine hydroxylase-positive (dopaminergic) neurons in subregions of the substantia nigra pars compacta at 3-4 days, 5 weeks, and 18 months of age. Both genotypes lost dopaminergic neurons with age and remaining neurons at 11 months were resilient to paraquat/maneb. In 5-week-old mice, the toxins decreased substantia nigra pars compacta dopaminergic neurons in both genotypes but less in DAT-KD. Regional analysis revealed striking differences in the subsets of neurons affected by low DAT, paraquat/maneb, and aging. In particular, we show that a potentially protective effect of low DAT against toxin exposure is not sufficient to reduce death of all nigrostriatal dopaminergic neurons. Thus, different regional vulnerability of nigrostriatal dopaminergic neurons may contribute to an increased risk of developing Parkinson's disease when multiple factors are combined.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Environmental toxins; Neurodegeneration; Parkinson's disease; Stereology

Mesh:

Substances:

Year:  2016        PMID: 28038352      PMCID: PMC5292275          DOI: 10.1016/j.neurobiolaging.2016.11.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  61 in total

1.  Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

Authors:  Phillip M Rappold; Mei Cui; Adrianne S Chesser; Jacqueline Tibbett; Jonathan C Grima; Lihua Duan; Namita Sen; Jonathan A Javitch; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Dopamine and Parkinson's disease: is the killer in the house?

Authors:  M-F Chesselet
Journal:  Mol Psychiatry       Date:  2003-04       Impact factor: 15.992

3.  Genetic-based, differential susceptibility to paraquat neurotoxicity in mice.

Authors:  Lina Yin; Lu Lu; Kavita Prasad; Eric K Richfield; Erica L Unger; Jialin Xu; Byron C Jones
Journal:  Neurotoxicol Teratol       Date:  2011-02-28       Impact factor: 3.763

4.  Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.

Authors:  Samir N Kelada; Paola Costa-Mallen; Harvey Checkoway; Christopher S Carlson; Terri-Smith Weller; Phillip D Swanson; Gary M Franklin; W T Longstreth; Zahra Afsharinejad; Lucio G Costa
Journal:  Pharmacogenet Genomics       Date:  2005-09       Impact factor: 2.089

5.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates.

Authors:  Brian K Barlow; Mona J Thiruchelvam; Lisa Bennice; Deborah A Cory-Slechta; Nazzareno Ballatori; Eric K Richfield
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

7.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

8.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

9.  Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.

Authors:  K Shimizu; K Matsubara; K Ohtaki; S Fujimaru; O Saito; H Shiono
Journal:  Brain Res       Date:  2003-06-27       Impact factor: 3.252

10.  Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter.

Authors:  R Bossé; F Fumagalli; M Jaber; B Giros; R R Gainetdinov; W C Wetsel; C Missale; M G Caron
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

View more
  11 in total

Review 1.  Mechanisms of Gene-Environment Interactions in Parkinson's Disease.

Authors:  Sheila M Fleming
Journal:  Curr Environ Health Rep       Date:  2017-06

2.  Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model.

Authors:  Christopher Käufer; Cara S Schreiber; Anna-Sophia Hartke; Ivo Denden; Stephanie Stanelle-Bertram; Sebastian Beck; Nancy Mounogou Kouassi; Georg Beythien; Kathrin Becker; Tom Schreiner; Berfin Schaumburg; Andreas Beineke; Wolfgang Baumgärtner; Gülsah Gabriel; Franziska Richter
Journal:  EBioMedicine       Date:  2022-04-16       Impact factor: 11.205

Review 3.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014

4.  Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice.

Authors:  Stefano Cataldi; Jordan Follett; Austen J Milnerwood; Matthew J Farrer; Jesse D Fox; Igor Tatarnikov; Chelsie Kadgien; Emil K Gustavsson; Jaskaran Khinda
Journal:  NPJ Parkinsons Dis       Date:  2018-08-21

5.  Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.

Authors:  Sarah Threlfell; Amir Saeid Mohammadi; Brent J Ryan; Natalie Connor-Robson; Nicola J Platt; Rishi Anand; Florence Serres; Trevor Sharp; Nora Bengoa-Vergniory; Richard Wade-Martins; Andrew Ewing; Stephanie J Cragg; Katherine R Brimblecombe
Journal:  Front Cell Neurosci       Date:  2021-04-15       Impact factor: 5.505

6.  Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study.

Authors:  Sida Han; Yiwei Feng; Min Guo; Yining Hao; Jian Sun; Yichen Zhao; Qiang Dong; Yanxin Zhao; Mei Cui
Journal:  Environ Health Perspect       Date:  2022-05-05       Impact factor: 9.031

7.  Effect of cyanocobalamin (vitamin B12) on paraquat-induced brain injury in mice.

Authors:  Marzieh Jafari Fakhrabad; Mohammad Moshiri; Fatemeh Ariakia; Vahid Reza Askari; Zahra Salmasi; Leila Etemad
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532

8.  Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A.

Authors:  Lijia Yu; Xijin Wang; Hanqing Chen; Zhiqiang Yan; Meihua Wang; Yunhong Li
Journal:  Front Neurosci       Date:  2017-11-23       Impact factor: 4.677

9.  Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease.

Authors:  Christin Helmschrodt; Sabrina Höbel; Sandra Schöniger; Anne Bauer; Jana Bonicelli; Marieke Gringmuth; Simone A Fietz; Achim Aigner; Angelika Richter; Franziska Richter
Journal:  Mol Ther Nucleic Acids       Date:  2017-08-30

Review 10.  Risk Factors for Brain Health in Agricultural Work: A Systematic Review.

Authors:  Emily Terese Sturm; Colton Castro; Andrea Mendez-Colmenares; John Duffy; Agnieszka Aga Z Burzynska; Lorann Stallones; Michael L Thomas
Journal:  Int J Environ Res Public Health       Date:  2022-03-13       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.